tirzepatide and mash in 🔴 #SYNERGY_NASH Trial (NEJM, 2024) for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis 👉 this phase 2 trial boron tirzepatide 8 2 mg Size and Gauge:31 Gauge, 1 cc, 1/4" Inch (6mm)

tirzepatide and mash in 🔴 #SYNERGY_NASH Trial (NEJM, 2024) for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis 👉 this phase 2 trial boron tirzepatide 8 2 mg Size and Gauge:31 Gauge, 1 cc, 1/4" Inch (6mm)

tirzepatide 8 2 mg ml Flex-Dose Injectable 10 mg/mL Tirzepatide - Injectable Peptide –

Available at: 131 Committee for Medicinal Products for Human Use (CHM)

boron

Size and Gauge:31 Gauge, 1 cc, 1/4" Inch (6mm)

Important safety information: Zepbound carries a boxed warning for risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)